Catalent vs Charles River Laboratories: CDMO Comparison
Side-by-side comparison of Catalent and Charles River Laboratories on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Key differences
- Charles River Laboratories carries a cleaner inspection mix — no OAI classifications versus 1 for Catalent.
- Catalent has 2 FDA warning letters on record; Charles River Laboratories has none.
- Catalent has stronger MHRA / UK coverage (16 compliant certificates vs 2).
- Composite Signal Score: Charles River Laboratories 92/100 vs Catalent 76/100 — a 15-point gap reflecting the combined quality, capacity and financial signal.
On a 13-modality CDMO landscape, both Catalent and Charles River Laboratories qualify as AAV manufacturers; Charles River Laboratories carries the higher composite Signal Score for AAV programs in this comparison.
What to evaluate for AAV programs
Both Catalent and Charles River Laboratories qualify as AAV CDMOs. When choosing between them for AAV programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.
Platform & scale
Suspension processes scale better than adherent (HEK293) for commercial volumes. Confirm the CDMO's largest validated bioreactor scale and serotype track record.
Capsid quality
Full/empty capsid ratio and aggregate control drive potency and safety. Ask about AUC, anion-exchange separation, and the analytics package for capsid characterization.
Regulatory readiness
For programs heading to BLA, a strong FDA inspection history and EMA/MHRA GMP coverage matter — both are shown above and on each profile.
Capacity & timelines
AAV manufacturing slots can be constrained. Weigh the capacity signal and clinical-program load before committing.
Frequently asked: Catalent vs Charles River Laboratories
Which has the stronger FDA inspection record, Catalent or Charles River Laboratories?
Catalent has 11 FDA inspections on record (NAI 3 / VAI 7 / OAI 1) and 2 warning letters. Charles River Laboratories has 8 FDA inspections on record (NAI 5 / VAI 3 / OAI 0) and 0 warning letters.
How do Catalent and Charles River Laboratories compare on European GMP coverage?
Catalent holds 17 active EMA GMP certificates and 16 MHRA / UK certificates. Charles River Laboratories holds 9 active EMA GMP certificates and 2 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.
Which is better for AAV manufacturing — Catalent or Charles River Laboratories?
Both Catalent and Charles River Laboratories are tagged as AAV CDMOs in our directory, so both are credible options for AAV programs. The most important differentiator for AAV selection is typically platform & scale: Suspension processes scale better than adherent (HEK293) for commercial volumes. Confirm the CDMO's largest validated bioreactor scale and serotype track record. Review each CDMO's profile and inspection record before shortlisting.
What does the Signal Score gap mean in practice?
Catalent carries a Signal Score of 76/100 and Charles River Laboratories carries 92/100 — a meaningful lead for Charles River Laboratories. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →